Cary Street Partners Investment Advisory’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,593
Closed -$767K 324
2020
Q4
$767K Buy
+10,593
New +$614K 0.15% 139

Other funds holding CDNA

Cary Street Partners Investment Advisory's CDNA Position: Q1 2021 in Review

Cary Street Partners Investment Advisory sold out of CareDx (CDNA) in Q1 2021, closing a stake of 10,593 shares — an estimated $767K sold.

Cary Street Partners Investment Advisory first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $767K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • Cary Street Partners Investment Advisory reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 10,593 CareDx shares in Q1 2021, an estimated $767K.
  • Cary Street Partners Investment Advisory first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's CareDx position peaked at $767K in Q4 2020.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2021, filed 17 May 2021.